Liver Cancer Diagnostics Market by Type (Imaging Tests, Laboratory Tests, Biopsy, Endoscopy, Others), by End-user (Academic & Research Institutes, Hospitals & Diagnostic Laboratories), and by Region - Global Forecast to 2023-2033

The liver cancer diagnostics market size is estimated to be USD 9,976.5 million in 2022 and is expected to witness a CAGR of 7.82% during the forecast period 2023-2033. Increasing prevalence of liver cancer, rising initiatives for launch and develop by companies and institutions are projected to drive the market growth in near future. Furthermore, increase in the number of initiatives to promote early detection of liver cancer is expected to support the market growth. However, high price of technologically advanced liver cancer diagnostic systems is expected to restrain the market growth.

Increasing prevalence of liver cancer is expected to fuel the market growth. Based on the American Cancer Society, the prevalence rate of liver cancer has nearly quadrupled and the death rates have more than doubled during the past three decades. The same source predicts that in 2021 there will be approximately 42,230 new cases of liver cancer diagnosed in the United States, resulting in about 30,230 deaths. Chronic viral hepatitis, cirrhosis, strong alcohol use, cigarette use, and obesity are the main risk factors for this disease.

Rising initiatives for launch and developed by companies and institutions is predicted to propel the market growth. Roche’s new Elecsys GALAD score was given the FDA’s Breakthrough Device Designation in March 2020. Elecsys GALAD score is made to assist physicians by giving them a prompt and precise hepatocellular cancer diagnosis. Similar to this, in November 2019, EXACT Sciences Corporation’s blood-based test for the early identification of liver cancer was given the FDA’s breakthrough designation.

Segmentation

 By Type

The market is categorized into imaging tests, laboratory tests, biopsy, endoscopy, and others. In 2022, the laboratory tests segment accounted for the highest revenue share due to their precision and affordability. Additionally, laboratory tests are used to screen high-risk individuals, determine different treatment options, localize disease stages, and assess whether a disease is responding to a certain course of treatment. The imaging testing segment had the second-largest revenue share, is expected to have significant growth over the course of the study period. Imaging tests can be used combination with genetic and laboratory studies to support the detection of tumors. Imaging tests include X-rays, ultrasounds, computed tomography (CT) scans, magnetic resonance imaging (MRI), and other radiographic exams.

By End User

The market is categorized into academic & research institutes, hospitals & diagnostic laboratories, and pharmaceutical & CRO laboratories. In the global market, the segment accounted for the largest revenue share in 2022 owing to the fact that hospitals and diagnostic labs are the main locations for the diagnosis and treatment of all chronic diseases. For the diagnosis and treatment of medical disorders including hepatocellular carcinoma, hospitals serve as primary care facilities. These long-term services are used by the majority of the population for disease management, diagnosis, and treatment. Additionally, diagnostic labs quickly and affordably produce data that are extremely sensitive. The pharmaceutical and CRO laboratories segment is anticipated to experience the quickest CAGR over the projection period. Leading pharmaceutical companies’ substantial demand for liver diagnostics products for research reasons can be attributed to this significant rise.

Regional Markets

In 2022, North America region accounted for the highest revenue in the liver cancer diagnostics market and is expected to maintain its dominance during the forecast period. This is attributed to its strong healthcare insurance programmes, developed healthcare infrastructure, and widespread use of cutting-edge diagnostic procedures. Leading players’ local presence and ongoing strategic activities by them also contribute to the growth of the region. The U.S. holds a large market share in North America due to a higher prevalence of hepatocellular carcinoma and widespread knowledge of its early identification. The market for liver cancer diagnostics in Asia Pacific is anticipated to develop at the greatest rate during the study period. The high incidence of hepatitis in developing nations like China and India is to responsible for this rapid development. Additional government measures to raise awareness about the early identification of liver cancer and surge in alcohol and cigarette use in the area are other factors impacting the market’s growth.

Competitor Insights

Some of the key players operating in the liver cancer diagnostics market are F. Hoffmann-La Roche Ltd., Illumina, Inc., Qiagen N.V., Epigenomics AG, Thermo Fisher Scientific, Inc., Becton Dickinson & Company, Abbott Laboratories, Koninklijke Philips N.V, Siemens Healthineers, and Fujifilm Medical Systems U.S.A., Inc.

To achieve a competitive edge, these businesses are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

  • For instance, Genomic Health was acquired by Exact Sciences for USD 2.8 billion in July 2019. Exact Sciences expanded its market reach for oncology diagnostics with this acquisition.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including type and end user from 2022 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 9,976.5 Million
CAGR
  • 7.82%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Type
  • End User
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Liver Cancer Diagnostics Market Report 2022 – 2033

Type (Revenue, USD Million), 2022 – 2033

  • Imaging Tests
  • Laboratory Tests
    • Blood Tests
    • Biomarkers
  • Biopsy
  • Endoscopy
  • Others

End user (Revenue, USD Million), 2022 – 2033

  • Academic & Research Institutes
  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & CRO Laboratories

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Liver Cancer Diagnostics Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: Liver Cancer Diagnostics
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Liver Cancer Diagnostics Market  
  3. Market Analysis by Type
    1. Imaging Tests
      1. Imaging Tests Market Forecast, 2022-2033(USD Million)
    2. Laboratory Tests
      1. Laboratory TestsMarket Forecast, 2022-2033 (USD Million)
        1. Blood Tests
          1. Blood TestsMarket Forecast, 2022-2033 (USD Million)
        2. Biomarkers
          1. BiomarkersMarket Forecast, 2022-2033 (USD Million)
        3. Biopsy
          1. Biopsy Market Forecast, 2022-2033(USD Million)
        4. Endoscopy
          1. Endoscopy Market Forecast, 2022-2033(USD Million)
        5. Others
          1. Others Market Forecast, 2022-2033(USD Million)
  1. Market Analysis byEnd User
    1. Academic & Research Institutes
      1. Academic & Research Institutes Market Forecast, 2022-2033(USD Million)
    2. Hospitals & Diagnostic Laboratories
      1. Hospitals & Diagnostic Laboratories Market Forecast, 2022-2033(USD Million)
    3. Pharmaceutical & CRO Laboratories
      1. Pharmaceutical & CRO Laboratories Market Forecast, 2022-2033(USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
  2. North America Liver Cancer Diagnostics Market  
    1. North America Liver Cancer Diagnostics Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Type, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. S. Liver Cancer Diagnostics Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Type, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. Canada Liver Cancer Diagnostics Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Type, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Europe Liver Cancer Diagnostics Market  
    1. Europe Liver Cancer Diagnostics Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Type, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. Germany Liver Cancer Diagnostics Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Type, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. UK Liver Cancer Diagnostics Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Type, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. France Liver Cancer Diagnostics Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Type, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
            2. Spain Liver Cancer Diagnostics Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Type, 2022-2033(USD Million)
                2. Market Size and Forecast by End User, 2022-2033(USD Million)
              2. Italy Liver Cancer Diagnostics Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Type, 2022-2033(USD Million)
                  2. Market Size and Forecast by End User, 2022-2033(USD Million)
                2. Rest of Europe Liver Cancer Diagnostics Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Type, 2022-2033(USD Million)
                    2. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Asia Pacific Liver Cancer Diagnostics Market  
    1. Asia Pacific Liver Cancer Diagnostics Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Type, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. Japan Liver Cancer Diagnostics Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Type, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. China Liver Cancer Diagnostics Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Type, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. India Liver Cancer Diagnostics Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Type, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
            2. South Korea Liver Cancer Diagnostics Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Type, 2022-2033(USD Million)
                2. Market Size and Forecast by End User, 2022-2033(USD Million)
                3. Market Size and Forecast by Device, 2022-2033(USD Million)
              2. Australia Liver Cancer Diagnostics Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Type, 2022-2033(USD Million)
                  2. Market Size and Forecast by End User, 2022-2033(USD Million)
                2. Rest of Asia Pacific Liver Cancer Diagnostics Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Type, 2022-2033(USD Million)
                    2. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Latin America Liver Cancer Diagnostics Market  
    1. Latin America Liver Cancer Diagnostics Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Type, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. Brazil Liver Cancer Diagnostics Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Type, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. Mexico Liver Cancer Diagnostics Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Type, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. Argentina Liver Cancer Diagnostics Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Type, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
            2. Rest of Latin America Liver Cancer Diagnostics Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Type, 2022-2033(USD Million)
                2. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. MEA Liver Cancer Diagnostics Market  
    1. MEA Liver Cancer Diagnostics Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Type, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
      2. GCC Liver Cancer Diagnostics Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Type, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
        2. South Africa Liver Cancer Diagnostics Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Type, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
          2. Rest of MEA Liver Cancer Diagnostics Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Type, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Hoffmann-La Roche Ltd.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Illumina, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Qiagen N.V.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Epigenomics AG
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. Thermo Fisher Scientific, Inc
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Becton Dickinson & Compan
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Abbott Laboratories
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Koninklijke Philips N.V
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Siemens Healthineers
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. Fujifilm Medical Systems U.S.A., Inc
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players
  3. Conclusion & Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.